BeOne Medicines Ag
(NASDAQ) ONC
BeOne Medicines Ag Financials at a Glance
Market Cap
$30.52B
Revenue (TTM)
$5.34B
Net Income (TTM)
$286.93M
EPS (TTM)
$2.52
P/E Ratio
109.11
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$274.90
Volume
9,164
Open
$273.91
Price
$274.90
Volume
9,164
Open
$273.91
Previous Close
$274.90
Daily Range
$273.91 - $278.97
52-Week Range
$196.45 - $385.22
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$274.90
Volume
9,164
Open
$273.91
Previous Close
$274.90
Daily Range
$273.91 - $278.97
52-Week Range
$196.45 - $385.22
ONC News
Why Shares of BeiGene Popped Today
ONC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BeOne Medicines Ag
Industry
Biotechnology
Sector
Health CareEmployees
12,000
CEO
John V. Oyler, MBA
Website
beonemedicines.comHeadquarters
US
ONC Financials
Key Financial Metrics (TTM)
Gross Margin
87%
Operating Margin
8%
Net Income Margin
5%
Return on Equity
7%
Return on Capital
7%
Return on Assets
3%
Earnings Yield
0.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$30.52B
Shares Outstanding
110.85M
Volume
9.16K
Short Interest
0.00%
Avg. Volume
270.43K
Financials (TTM)
Gross Profit
$4.67B
Operating Income
$447.14M
EBITDA
$616.77M
Operating Cash Flow
$1.13B
Capital Expenditure
$185.84M
Free Cash Flow
$941.74M
Cash & ST Invst.
$4.55B
Total Debt
$2.00B
BeOne Medicines Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.50B
+32.8%
Gross Profit
$1.36B
+40.2%
Gross Margin
90.49%
N/A
Market Cap
$30.52B
N/A
Market Cap/Employee
$2.77M
N/A
Employees
11,000
N/A
Net Income
$66.50M
+143.8%
EBITDA
$417.58M
+1531.1%
Quarterly Fundamentals
Net Cash
$2.55B
+64.6%
Accounts Receivable
$865.08M
+22.0%
Inventory
$608.23M
+22.9%
Long Term Debt
$1.87B
+784.9%
Short Term Debt
$134.71M
-84.5%
Return on Assets
3.50%
N/A
Return on Invested Capital
7.03%
N/A
Free Cash Flow
$131.28M
+857.9%
Operating Cash Flow
$417.35M
+455.3%